BSE filing, NSE: NH. Summary written from the filing by ALFA Finder's alert engine.
Narayana Hrudayalaya Ltd: key numbers
- Share price
- ₹1,931.50
- Market cap
- ₹39,472 Cr
- Revenue (annual)
- ₹7,896 Cr
- Net profit (annual)
- ₹805.6 Cr
- P/E (TTM)
- 46.0×Sector 54.5×
- Promoter holding
- 63.27%+0.00% QoQ
- FII holding
- 9.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Narayana Hrudayalaya Ltd
All →Narayana Hrudayalaya Other Announcement
Narayana Hrudayalaya filed a Regulation 54 security cover statement for the quarter ended September 30, 2026. The NCDs are unsecured, so the cover requirement does not apply.
Narayana Hrudayalaya Results Update
Narayana Hrudayalaya reported Q2 FY27 consolidated revenue of Rs 28,440 Mn, up 73% YoY. PAT rose 16.6% to Rs 3,012 Mn, with the UK acquisition boosting revenue.
Narayana Hrudayalaya Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹28,440 Mn (+73% YoY), EBITDA ₹6,054 Mn (21.3% margin), PAT ₹3,012 Mn (10.6% margin). Growth from capacity expansion and UK consolidation.
Narayana Hrudayalaya Q2 FY27 Results: Net Profit ₹301.2 Cr, Up 16.5% YoY
Narayana Hrudayalaya Ltd reported revenue from operations of ₹2,844 Cr (+73.0% YoY) and net profit of ₹301.2 Cr (+16.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹301.2 Cr · +16.5% YoY
Narayana Hrudayalaya Board Meeting Date
Narayana Hrudayalaya will hold a board meeting on 30 October 2026 to consider unaudited results. Results are not yet approved.
Narayana Hrudayalaya Other Announcement
Narayana Hrudayalaya Ltd submitted its shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Other merger & restructuring announcements
All →Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr
HEG Advanced Materials Merger & Restructuring Worth ₹10.12 Cr
HEG Advanced Materials closed LNJ Trading FZCO, its Dubai-based wholly owned subsidiary, as part of overseas structure rationalisation. The filing quantifies the effect at AED 4,048,000.
- Value
- ₹10.12 Cr